HEADER ENDOCYTOSIS/EXOCYTOSIS 22-MAY-05 2CSP TITLE SOLUTION STRUCTURE OF THE FNIII DOMAIN OF HUMAN RIM-BINDING PROTEIN 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIM BINDING PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FN3 DOMAIN; COMPND 5 SYNONYM: RIM-BP2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KAZUSA CDNA HG00364; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P040705-13; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS FN3 DOMAIN, RIM BINDING PROTEIN 2, RIM-BP2, STRUCTURAL GENOMICS, KEYWDS 2 NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL KEYWDS 3 ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, KEYWDS 4 ENDOCYTOSIS-EXOCYTOSIS COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.INOUE,F.HAYASHI,S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2CSP 1 REMARK SEQADV REVDAT 2 24-FEB-09 2CSP 1 VERSN REVDAT 1 22-NOV-05 2CSP 0 JRNL AUTH K.INOUE,F.HAYASHI,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE FNIII DOMAIN OF HUMAN RIM-BINDING JRNL TITL 2 PROTEIN 2 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CYANA 2.0.17 REMARK 3 AUTHORS : VARIAN (VNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CSP COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000024579. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.09MM U-15N, 13C-LABELED REMARK 210 PROTEIN; 20MM D-TRIS-HCL; 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20031121, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9296, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION,STRUCTURES WITH REMARK 210 THE LOWEST ENERGY,STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 2 83.57 -68.97 REMARK 500 1 VAL A 8 110.20 -39.58 REMARK 500 1 GLN A 27 -75.73 -86.27 REMARK 500 1 ALA A 28 139.23 -175.77 REMARK 500 1 VAL A 30 -26.85 -38.16 REMARK 500 1 THR A 45 157.63 -37.27 REMARK 500 1 PRO A 46 15.00 -69.75 REMARK 500 1 SER A 50 -73.79 -82.59 REMARK 500 1 ALA A 62 -74.61 -108.55 REMARK 500 1 ILE A 71 43.64 -79.64 REMARK 500 1 SER A 77 136.83 -172.30 REMARK 500 1 VAL A 105 170.06 -54.98 REMARK 500 1 SER A 107 -178.04 -62.25 REMARK 500 1 ALA A 108 108.51 -55.78 REMARK 500 1 VAL A 109 104.93 -49.39 REMARK 500 1 ALA A 111 108.93 -59.77 REMARK 500 2 GLN A 27 -75.45 -93.11 REMARK 500 2 ALA A 28 135.20 -175.85 REMARK 500 2 VAL A 30 -34.62 -35.58 REMARK 500 2 THR A 45 157.70 -37.22 REMARK 500 2 PRO A 46 14.77 -69.76 REMARK 500 2 ALA A 62 -70.39 -108.77 REMARK 500 2 ARG A 66 108.71 -47.96 REMARK 500 2 ILE A 71 46.08 -77.56 REMARK 500 2 SER A 77 130.67 -173.14 REMARK 500 2 VAL A 105 163.43 -46.78 REMARK 500 2 SER A 107 178.09 -59.25 REMARK 500 2 VAL A 109 104.72 -53.76 REMARK 500 3 THR A 12 41.19 -100.65 REMARK 500 3 GLN A 27 -76.05 -90.90 REMARK 500 3 ALA A 28 134.25 -176.26 REMARK 500 3 VAL A 30 -28.25 -37.50 REMARK 500 3 THR A 45 157.87 -37.64 REMARK 500 3 PRO A 46 15.71 -69.79 REMARK 500 3 SER A 50 -73.34 -86.65 REMARK 500 3 ILE A 71 45.22 -77.70 REMARK 500 3 SER A 107 179.04 -57.12 REMARK 500 3 VAL A 109 104.96 -54.34 REMARK 500 3 HIS A 123 141.31 -38.68 REMARK 500 4 GLU A 9 148.37 -38.69 REMARK 500 4 GLN A 27 -75.44 -93.55 REMARK 500 4 ALA A 28 134.68 -175.69 REMARK 500 4 VAL A 30 -33.67 -38.86 REMARK 500 4 THR A 45 158.12 -37.25 REMARK 500 4 PRO A 46 16.11 -69.77 REMARK 500 4 SER A 50 -63.21 -94.67 REMARK 500 4 ALA A 62 -67.33 -121.29 REMARK 500 4 ILE A 71 46.09 -77.44 REMARK 500 4 SER A 77 130.16 -171.49 REMARK 500 4 GLU A 103 -174.67 -51.95 REMARK 500 REMARK 500 THIS ENTRY HAS 258 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK002000310.4 RELATED DB: TARGETDB DBREF 2CSP A 8 124 UNP O15034 RIMB2_HUMAN 477 593 SEQADV 2CSP GLY A 1 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 2 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 3 UNP O15034 CLONING ARTIFACT SEQADV 2CSP GLY A 4 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 5 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 6 UNP O15034 CLONING ARTIFACT SEQADV 2CSP GLY A 7 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 125 UNP O15034 CLONING ARTIFACT SEQADV 2CSP GLY A 126 UNP O15034 CLONING ARTIFACT SEQADV 2CSP PRO A 127 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 128 UNP O15034 CLONING ARTIFACT SEQADV 2CSP SER A 129 UNP O15034 CLONING ARTIFACT SEQADV 2CSP GLY A 130 UNP O15034 CLONING ARTIFACT SEQRES 1 A 130 GLY SER SER GLY SER SER GLY VAL GLU PHE SER THR LEU SEQRES 2 A 130 PRO ALA GLY PRO PRO ALA PRO PRO GLN ASP VAL THR VAL SEQRES 3 A 130 GLN ALA GLY VAL THR PRO ALA THR ILE ARG VAL SER TRP SEQRES 4 A 130 ARG PRO PRO VAL LEU THR PRO THR GLY LEU SER ASN GLY SEQRES 5 A 130 ALA ASN VAL THR GLY TYR GLY VAL TYR ALA LYS GLY GLN SEQRES 6 A 130 ARG VAL ALA GLU VAL ILE PHE PRO THR ALA ASP SER THR SEQRES 7 A 130 ALA VAL GLU LEU VAL ARG LEU ARG SER LEU GLU ALA LYS SEQRES 8 A 130 GLY VAL THR VAL ARG THR LEU SER ALA GLN GLY GLU SER SEQRES 9 A 130 VAL ASP SER ALA VAL ALA ALA VAL PRO PRO GLU LEU LEU SEQRES 10 A 130 VAL PRO PRO THR PRO HIS PRO SER GLY PRO SER SER GLY HELIX 1 1 LEU A 82 GLU A 89 1 8 HELIX 2 2 PRO A 113 VAL A 118 1 6 SHEET 1 A 3 GLN A 22 VAL A 26 0 SHEET 2 A 3 THR A 34 ARG A 40 -1 O ARG A 40 N GLN A 22 SHEET 3 A 3 SER A 77 GLU A 81 -1 O THR A 78 N VAL A 37 SHEET 1 B 3 ARG A 66 VAL A 70 0 SHEET 2 B 3 VAL A 55 TYR A 61 -1 N TYR A 58 O VAL A 70 SHEET 3 B 3 THR A 94 SER A 99 -1 O LEU A 98 N GLY A 57 CISPEP 1 GLY A 16 PRO A 17 1 0.04 CISPEP 2 GLY A 16 PRO A 17 2 0.06 CISPEP 3 GLY A 16 PRO A 17 3 0.03 CISPEP 4 GLY A 16 PRO A 17 4 0.03 CISPEP 5 GLY A 16 PRO A 17 5 0.08 CISPEP 6 GLY A 16 PRO A 17 6 0.14 CISPEP 7 GLY A 16 PRO A 17 7 -0.05 CISPEP 8 GLY A 16 PRO A 17 8 0.06 CISPEP 9 GLY A 16 PRO A 17 9 0.08 CISPEP 10 GLY A 16 PRO A 17 10 0.13 CISPEP 11 GLY A 16 PRO A 17 11 0.09 CISPEP 12 GLY A 16 PRO A 17 12 0.07 CISPEP 13 GLY A 16 PRO A 17 13 0.03 CISPEP 14 GLY A 16 PRO A 17 14 0.08 CISPEP 15 GLY A 16 PRO A 17 15 0.12 CISPEP 16 GLY A 16 PRO A 17 16 0.14 CISPEP 17 GLY A 16 PRO A 17 17 0.09 CISPEP 18 GLY A 16 PRO A 17 18 -0.01 CISPEP 19 GLY A 16 PRO A 17 19 0.05 CISPEP 20 GLY A 16 PRO A 17 20 0.10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1